This study aims to evaluate the effects of NACT on estrogen receptor (ER), progesterone receptor (PR), HER2 status, and Ki67 index, which are crucial markers for breast cancer prognosis and treatment decisions. This evidence concerns the gene ESR1 and breast carcinoma.